机构:[a]Beijing Hospital of the Ministry of Health, Beijing, 100730, China[b]First Hospital of Tsinghua University, Beijing, 100016, China[c]Binzhou Medical University Hospital of Shandong Province, Binzhou, 256603, China[d]First Affiliated Hospital of Kunming Medical University, Kunming, 650000, China昆明医科大学附属第一医院[e]Peking University People's Hospital, Beijing, 100044, China
Objective: To observe the in vivo anti-hepatoma and anti-angiogenetic effects of isomalto oligosaccharide (IMO), and to preliminarily investigate its anti-tumor mechanism.
语种:
中文
第一作者:
第一作者机构:[a]Beijing Hospital of the Ministry of Health, Beijing, 100730, China
通讯作者:
推荐引用方式(GB/T 7714):
Li H.-Y,Chen P.-C,Chen X.-F,等.Antitumor and anti-angiogenic effects of isomalto oligosaccharide on human hepatocellular carcinoma HepG2 xenografts in nude mice[J].Chinese Journal of New Drugs.2014,23(17):